We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Throughout the year, you will have the opportunity to participate in campaigns that support endocrinology research, care, professionals, and patients. Contact us to get more involved: [email protected].
Taking action by sending messages to your Congressional delegation makes a difference, and our online campaigns make it easy to do. Don't take it from us, hear from Rosa DeLauro, Ranking Member of the House Appropriations Committee, why your voice matters.
The administration has abruptly cancelled all National Institutes of Health (NIH) funding for the Diabetes Prevention Program. The loss of this ongoing research, which is being conducted at 30 institutions in 21 states, will impact tens of millions of people who have Type 2 diabetes and prediabetes nationwide. This program has followed thousands of participants since its creation in 1996 and has provided an important source of long-term information on diabetes prevention. Every Senator and Representative needs to hear from their constituents that it is critical this program is restored immediately.
Since January, there have been multiple actions to cut federal funding of research including an attempt to freeze all grants and an announcement that would limit indirect costs for NIH grants to 15%. These efforts would cause major harm to institution budgets, jeopardize lifesaving medical research, cause layoffs, suspend clinical trials, and disrupt ongoing research and laboratory support programs. While federal judges have blocked these actions at least temporarily, we are concerned there will be further efforts to cut federal funding of research. Endocrine Society members are encouraged to join our campaign to share with your US Representative and Senators how cutting federal funding for your research would impact your work.
Congress is in the process of determining funding for the National Institutes of Health (NIH) for Fiscal Year 2026 (FY26). This will affect all researchers who receive grant funding from NIH. Funding for NIH is at risk as the administration and some Members of Congress are seeking cuts to federal support for biomedical research. The Endocrine Society is urging Congress to continue its bipartisan support for NIH and provide the agency with at least $51.303 billion. It is imperative that all Senators and Representatives hear from their constituents about the importance of this issue.
Read our newsletters covering the latest science-based information on endocrine-disrupting chemicals (EDCs) for policymakers in the European Union.
